DRW Securities LLC Acquires New Stake in Axon Enterprise, Inc. (NASDAQ:AXON)

DRW Securities LLC acquired a new stake in Axon Enterprise, Inc. (NASDAQ:AXON) during the third quarter, Holdings Channel reports. The fund acquired 729 shares of the biotechnology company’s stock, valued at approximately $291,000.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Harvest Fund Management Co. Ltd raised its position in shares of Axon Enterprise by 3,792.2% in the third quarter. Harvest Fund Management Co. Ltd now owns 1,985 shares of the biotechnology company’s stock valued at $793,000 after buying an additional 1,934 shares during the last quarter. Daiwa Securities Group Inc. grew its stake in Axon Enterprise by 10.9% during the 3rd quarter. Daiwa Securities Group Inc. now owns 9,927 shares of the biotechnology company’s stock valued at $3,967,000 after acquiring an additional 973 shares in the last quarter. SevenBridge Financial Group LLC acquired a new stake in Axon Enterprise in the 3rd quarter valued at about $267,000. Westfield Capital Management Co. LP lifted its stake in Axon Enterprise by 12.2% in the 3rd quarter. Westfield Capital Management Co. LP now owns 1,175,328 shares of the biotechnology company’s stock worth $469,661,000 after purchasing an additional 127,769 shares in the last quarter. Finally, Centaurus Financial Inc. boosted its holdings in shares of Axon Enterprise by 22.8% during the 3rd quarter. Centaurus Financial Inc. now owns 4,528 shares of the biotechnology company’s stock worth $1,809,000 after purchasing an additional 840 shares during the last quarter. Institutional investors and hedge funds own 79.08% of the company’s stock.

Insider Transactions at Axon Enterprise

In other Axon Enterprise news, CEO Patrick W. Smith sold 75,000 shares of the business’s stock in a transaction dated Tuesday, September 3rd. The shares were sold at an average price of $356.53, for a total transaction of $26,739,750.00. Following the sale, the chief executive officer now directly owns 2,970,366 shares in the company, valued at $1,059,024,589.98. This represents a 2.46 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, President Joshua Isner sold 20,000 shares of the stock in a transaction dated Tuesday, November 12th. The stock was sold at an average price of $606.15, for a total transaction of $12,123,000.00. Following the sale, the president now directly owns 208,166 shares in the company, valued at $126,179,820.90. This represents a 8.77 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 260,256 shares of company stock worth $105,984,120 over the last ninety days. Company insiders own 5.70% of the company’s stock.

Analyst Ratings Changes

AXON has been the subject of several recent research reports. Barclays increased their price target on Axon Enterprise from $381.00 to $387.00 and gave the company an “overweight” rating in a report on Wednesday, August 7th. Needham & Company LLC lifted their price target on Axon Enterprise from $525.00 to $600.00 and gave the stock a “buy” rating in a report on Friday, November 8th. JMP Securities boosted their price target on shares of Axon Enterprise from $430.00 to $500.00 and gave the company a “market outperform” rating in a research report on Thursday, October 31st. The Goldman Sachs Group raised their price objective on shares of Axon Enterprise from $385.00 to $441.00 and gave the stock a “buy” rating in a research report on Wednesday, October 23rd. Finally, Craig Hallum boosted their target price on shares of Axon Enterprise from $370.00 to $376.00 and gave the company a “buy” rating in a report on Wednesday, August 7th. Two equities research analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company’s stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $427.83.

Axon Enterprise Stock Up 0.4 %

Axon Enterprise stock opened at $634.96 on Thursday. The company has a market capitalization of $48.42 billion, a PE ratio of 162.65, a price-to-earnings-growth ratio of 13.62 and a beta of 0.94. The company has a debt-to-equity ratio of 0.32, a quick ratio of 2.63 and a current ratio of 2.96. Axon Enterprise, Inc. has a fifty-two week low of $224.28 and a fifty-two week high of $641.20. The firm has a 50 day moving average price of $473.23 and a 200 day moving average price of $372.97.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.